Targeting Mitochondrial Dysfunction for Bipolar Disorder

Curr Top Behav Neurosci. 2021:48:61-99. doi: 10.1007/7854_2020_152.

Abstract

People with bipolar disorder (BD) all too often have suboptimal long-term outcomes with existing treatment options. They experience relapsing episodes of depression and mania and also have interepisodic mood and anxiety symptoms. We need to have a better understanding of the pathophysiology of BD if we are to make progress in improving these outcomes. This chapter will focus on the critical role of mitochondria in human functioning, oxidative stress, and the biological mechanisms of mitochondria in BD. Additionally, this chapter will present the evidence that, at least for some people, BD is a product of mitochondrial dysregulation. We review the modulators of mitochondria, the connection between current BD medication treatments and mitochondria, and additional medications that have theoretical potential to treat BD.

Keywords: Bipolar disorder; Medication; Mitochondria; Treatment.

Publication types

  • Review

MeSH terms

  • Affect
  • Bipolar Disorder* / drug therapy
  • Bipolar Disorder* / metabolism
  • Humans
  • Mitochondria / metabolism
  • Oxidative Stress